Home › NDC Lookup › RxCUI directory › RxCUI 577154

Megestrol acetate 125 MG/ML Oral Suspension — RxCUI 577154

RxNorm drug concept · Semantic clinical drug
RxCUI 577154 Semantic clinical drug · SCD ● Current RxNorm concept 2 FDA products 3 package NDCs Snapshot Jul 14, 2026

This page is curated, coded, and maintained by

Compiled from public NLM RxNorm and FDA (openFDA NDC directory) data sources. Editorial policy

What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.

🗂️ Key Facts

RxCUI577154
Official nameMegestrol acetate 125 MG/ML Oral Suspension
Concept typeSemantic clinical drug (SCD)
RxNorm statusCurrent RxNorm concept
Also known asmegestrol acetate 625 MG per 5 ML Oral Suspension; megestrol acetate 625 MG in 5 mL Oral Suspension
FDA products mapped2
Package NDCs mapped3
Reported Medicaid activity (SDUD)1,961 prescriptions · 22 state & territory Medicaid programs · latest period Q4 2025
RxNorm release07/06/2026
Snapshot dataJul 14, 2026

📖 Skip the Codes — Read It in Plain English.

Our pharmacist-built guide to Megestrol: what it is, how it’s used, side effects, and interactions.

📗 Our plain-language guide HelloPharmacist
  • It depends on the form you have. The liquid suspension is used specifically to treat serious appetite loss and weight loss in people with AIDS — your doctor would have prescribed i...
  • What exactly is megestrol acetate used for?
  • Yes — the 125 mg/mL suspension can be taken with or without food, so you don't need to worry about timing it around meals. Just make sure to shake the bottle well before each dose....
  • Can I take the oral suspension with food?
📖 Read our full Megestrol guide →

🕸️ Concept Web — How Megestrol acetate 125 MG/ML Oral Suspension Connects

One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept Megestrol acetate 125 MG/ML Oral Suspension RxCUI 577154

Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.

  1. Ingredients 2

    The active substance itself — no strength, form, or brand attached yet.

    • Megestrol 6703
    • Megestrol acetate 29451
  2. Dose forms 9

    The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.

    • Megestrol Oral Suspension 372747
    • Megestrol acetate Oral Suspension 2645795
    • Megestrol Oral Liquid Product 1159210
    • Megestrol Oral Product 1159211
    • Megestrol acetate Oral Liquid Product 2663330
    • Megestrol acetate Oral Product 2661161
    • Oral Suspension 316969
    • Oral Liquid Product 1151137
    • +1 more in this family
  3. Clinical & branded drugs 1

    Ingredient + strength + dose form. These are the concepts real FDA products actually carry.

    • Megestrol acetate 125 MG/ML 577152

Showing up to 8 concepts per family — 11 of 12 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.

🔀 Generic ⇄ Brand Crosswalk

The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.

Generic (Clinical) Concepts

  • Megestrol acetate 125 MG/ML SCDC · 577152
  • Megestrol Oral Suspension SCDF · 372747
  • Megestrol acetate Oral Suspension SCDFP · 2645795
  • Megestrol Oral Liquid Product SCDG · 1159210
  • Megestrol Oral Product SCDG · 1159211
  • Megestrol acetate Oral Liquid Product SCDGP · 2663330
  • Megestrol acetate Oral Product SCDGP · 2661161

📦 FDA Products & Package NDCs

2 products · 3 package NDCs
3 package NDCs map to RxCUI 577154 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
Package NDC Package Brand / generic name Labeler Marketing start
24979-0041-13 150 mL in 1 BOTTLE (24979-041-13) Megestrol Acetate Upsher-Smith Laboratories, LLC 2015-07-28
24979-0041-35 35 mL in 1 BOTTLE (24979-041-35) Megestrol Acetate Upsher-Smith Laboratories, LLC 2025-12-01
71205-0943-15 150 mL in 1 BOTTLE (71205-943-15) Megestrol Acetate Proficient Rx LP 2020-11-19
Observed labelers: Upsher-Smith Laboratories, LLC (2) · Proficient Rx LP (1) — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.

💲 Pricing (NADAC)

NADAC is CMS's National Average Drug Acquisition Cost — roughly what pharmacies pay to buy the drug. It is an acquisition benchmark, not your copay.
Per ml · median
$1.2584
Range $1.2584–$1.2584 · middle 50% $1.2584–$1.2584 · 1 NDCs
Latest compatible distributions from the CMS NADAC file · dataset watermark 2026-07-10. Prices vary by package and pharmacy; a distribution is shown instead of one misleading number. Rows the dataset is silent on carry no price. No zero-cost conclusion should be drawn.

🗃️ Sources & Limits

Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
  • A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
  • Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
  • Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
  • Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.

Machine-readable JSON

Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.